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Abstract  23 
Purpose: Cigarette smoking is the main risk factor for chronic obstructive pulmonary disease and 24 
emphysema. However, evidence on the extrapulmonary effects of smoke exposure that precede 25 
lung impairments remains unclear at present, as are data on non-pharmacological treatments such 26 
as exercise training.  27 
Methods: Three groups of mice including control (n=10), smoking (n=10), and smoking with 6 28 
weeks of high-intensity interval treadmill running (n=11) were exposed to 20 weeks of fresh air or 29 
whole-body cigarette smoke. Exercise capacity (peak oxygen uptake) and lung destruction 30 
(histology) were subsequently measured, while the heart, peripheral endothelium (aorta), and 31 
respiratory (diaphragm) and limb (extensor digitorum longus and soleus) skeletal muscles were 32 
assessed for in vivo and in vitro function, in situ mitochondrial respiration, and molecular 33 
alterations.  34 
Results: Smoking reduced body weight by 26% (P<0.05) without overt airway destruction 35 
(P>0.05). Smoking impaired exercise capacity by 15% while inducing right ventricular dysfunction 36 
by ~20%, endothelial dysfunction by ~20%, and diaphragm muscle weakness by ~15% (all 37 
P<0.05), but these were either attenuated or reversed by exercise training (P<0.05). Compared to 38 
controls, smoking mice had normal limb muscle and mitochondrial function (cardiac and skeletal 39 
muscle fibers), however diaphragm measures of oxidative stress and protein degradation were 40 
increased by 111% and 65% (P<0.05), but these were attenuated by exercise training (P<0.05).  41 
Conclusions: Prolonged cigarette smoking reduced exercise capacity concomitant with functional 42 
impairments to the heart, peripheral endothelium, and respiratory muscle that preceded the 43 
development of overt emphysema. However, high-intensity exercise training was able to reverse 44 
these smoke-induced extrapulmonary impairments. 45 
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Introduction  48 
Cigarette smoking is the main risk factor for chronic obstructive pulmonary disease (COPD). This 49 
is characterized not only by airway destruction and airflow limitation but also extrapulmonary 50 
impairments to the heart (12, 25), peripheral vasculature (6, 27), and skeletal muscles (2, 3, 18, 24), 51 
which collectively exacerbate the key symptom of exercise intolerance. Interestingly, initial 52 
evidence suggests that smokers at risk of COPD may also suffer extrapulmonary impairments 53 
similar to those demonstrated in smokers with CODP (11, 31). However, data detailing the 54 
extrapulmonary effects of prolonged smoke exposure in the period preceding COPD remain 55 
unclear at present, as are data on potential favorable therapeutic interventions. For example, it still 56 
remains unknown whether smoke-induced extrapulmonary impairments in the heart, endothelium, 57 
and respiratory and limb skeletal muscle occur in parallel as a direct consequence to cigarette 58 
smoke (i.e., primary effect) or as an indirect consequence following the subsequent development 59 
of emphysema (i.e., secondary effect) (2, 3, 7, 13). In addition, data on whether prolonged smoke 60 
exposure induces skeletal muscle dysfunction in the lower limbs remains controversial, with some 61 
(24, 28) but not all (7, 34) studies reporting impairments. Further, whether smoking directly induces 62 
respiratory (i.e., diaphragm) fiber contractile dysfunction remains unknown, despite the diaphragm 63 
playing a direct role in the pathogenesis of dyspnea in smokers (11) and also not being affected by 64 
disuse (as is common for the lower limb muscles (7)). As such, more evidence is needed to clarify 65 
the role of cigarette smoke on respiratory and limb skeletal muscle contractile function.  66 
 67 
Interestingly, physical inactivity has recently been demonstrated to exacerbate the extrapulmonary 68 
impairments associated with prolonged cigarette smoking (7), while exercise training has been 69 
shown to reverse smoke-induced cardiac dysfunction in mice (15). Yet whether exercise training 70 
can also reverse numerous smoke-induced systemic impairments related not only to cardiac 71 
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function but also to the peripheral endothelium as well as respiratory and locomotor skeletal 72 
muscles remains unknown. In this study, therefore, we exposed mice to cigarette smoke followed 73 
by the intervention of high-intensity exercise training and used an integrative approach by 74 
combining measures of the lung and exercise capacity in parallel with multiple-extrapulmonary 75 
organs. We hypothesized that cigarette exposure would impair cardiac, endothelial, respiratory and 76 
limb muscle function prior to the development of overt emphysema, and that exercise training 77 
would be able to attenuate such impairments.  78 
 79 
 80 
81 
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Materials and Methods  82 
Animals and smoke exposure 83 
Ten week old A/JOlaHsd female mice (Harlan Laboratories, UK) were used in this study, as 84 
approved by the Norwegian Animal Research Authority and in accordance with ACSM¶VDQLPDO85 
care standards. This study lasted a total of 26 weeks: 0-20 weeks mice were exposed to either fresh-86 
air or cigarette smoke; 20-26 weeks mice performed exercise training or remained sedentary; week 87 
26 mice were sacrificed. Briefly, mice were randomly separated into three groups to receive either: 88 
(1) fresh air (control mice; n=10); (2) cigarette smoke (smoking mice; n=10); and (3) cigarette 89 
smoke and high-intensity interval exercise training (smoking+HIIT mice; n=11). The exposure 90 
period consisted of 6 hours per day for 5 days a week and this was achieved by placing mice in a 91 
chamber connected to a smoking device (TE-10, Teague Enterprises, California, US), which 92 
provided fresh air or cigarette smoke (Research Cigarettes 3R4F, University of Kentucky, 93 
Lexington, US). The total particulate matter (TPM) was 100 mg/m3 for the first 2 weeks and 200 94 
mg/m3 for the remaining exposure time (a level of 250 TPM has been suggested to be equivalent 95 
to humans smoking around 15 packs per day (21)), which was monitored weekly and measured 96 
with gravimetric method as previously described (20). The exposure period was terminated after 97 
20 weeks and the exercise training intervention was then performed.  98 
 99 
Exercise training and exercise capacity  100 
High-intensity interval training (HIIT) was performed on a treadmill (25° incline) 5 times per week 101 
over 6 weeks. Each session consisted of 10 intervals (4 min at ~90 % peak work rate) separated by 102 
2 min recovery (~60% peak work rate). Exercise capacity was assessed in all mice by measuring 103 
peak oxygen uptake (9ሶ 2peak) in ml/min via a closed metabolic chamber, as previously described 104 
(17). 105 
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 106 
In vivo cardiac function and hemodynamics 107 
Echocardiography was performed as previously described (15). Briefly, in the week before 108 
sacrifice mice were anesthetized with 2 % isoflurane adjusted to maintain similar heart- and 109 
respiration rates between animals. The echocardiography system with a 24 MHz probe was used 110 
to determine both right and left ventricular function (Vevo 2100 Visual Sonics, Toronto, Canada). 111 
Right ventricular systolic function was assessed by measuring the tricuspid annular plane systolic 112 
excursion (TAPSE), which was defined as the differences in systolic and diastolic displacement of 113 
the right ventricular base, as obtained from the apical four chamber view in B-mode. This included 114 
the M-mode cursor being oriented to the junction of the tricuspid valve plane in the right ventricular 115 
IUHHZDOODQGWKURXJKWKHDSH[5LJKWYHQWULFXODUV\VWROLFYHORFLW\596¶ZDVREWDLQHGIURPWKH116 
apical four chamber view using tissue Doppler from the lateral wall close to the tricuspid inflow. 117 
Pulmonary acceleration time (PAP), defined as the onset of pulmonary flow to the peak flow, was 118 
measured using pulsed-wave Doppler in the short-axis view at the level of the aortic valve. In 119 
addition left ventricular function was assessed using B-mode images in the parasternal short axis 120 
view to calculate left ventricular ejection fraction (LVEF), while left ventricular fractional 121 
shortening (LVFS) was calculated in M-mode. In vivo hemodynamics of the right ventricular 122 
systolic pressure was also determined as previously described (33). Briefly, immediately prior to 123 
sacrifice the mice were anesthetized with 2 % isoflurane under spontaneous breathing and the 124 
external jugular vein was dissected free and a 1.2 F pressure catheter inserted to determine right 125 
ventricular systolic pressure (Scisense pressure catheter FTH-1211B-0018, Scisense Inc, Canada). 126 
Data were acquired with Advantage PV System ADV500 (Transonic Inc, Canada). Body 127 
temperature was measured with a rectal probe, which was kept constant at 37.5°C during the 128 
experiment. The animal was observed until stable readings before recording. The animals were 129 
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killed immediately following the recordings by removal of the heart. Data were analyzed with 130 
LabChart version 7 (ADInstruments, UK). Right ventricular systolic pressure was used an index 131 
of pulmonary hypertension, which is usually developed during emphysema.  132 
 133 
Lung emphysema  134 
The right lung was inflated by instilling a 4 % formaldehyde phosphate buffered solution via the 135 
trachea at a pressure of 25 cm H2O. It was maintained to fixate like this for a minimum of 15 min 136 
before ligating the right main bronchus and putting the whole specimen in formaldehyde solution. 137 
Later, it was paraffin-embedded, sectioned, and stained with hematoxylin, eosin and saffron. Light 138 
microscopy was then used to identify suitable areas free from artefacts and 4-8 images per animal 139 
were selected on a random basis. A reference grid was placed on images in order to count the points 140 
of intercepts between the grid lines and alveolar walls, followed by dividing this number by the 141 
total length of all grid lines, in order to determine the mean linear intercept length (Lm), as 142 
previously detailed (10).  143 
 144 
In vitro skeletal muscle function  145 
A diaphragm strip, the soleus, and the extensor digitorum longus (EDL) were isolated and 146 
stimulated across a range of frequencies for measurement of in vitro isometric contractile function, 147 
as previously described (5). Muscle force (N) was normalized to muscle cross-sectional area (cm2) 148 
by dividing muscle mass (g) by the product of Lo (cm) and estimated muscle density (1.06) (8), 149 
which allowed specific force in N/cm2 to be calculated.   150 
 151 
In vitro peripheral vascular endothelial function  152 
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To provide an index of vascular function, aortic rings (n=4) were dissected from mice and mounted 153 
in a buffer-filled (in mmol/L: 118 NaCl, 25 NaHCO3, 4.7 KCl, 1.2 KH2PO4, 1.2 MgSO4, 2.5 CaCl2, 154 
5.5 glucose) organ bath between a hook and a force transducer, as previously described (1). After 155 
30 min of equilibrium, the maximal constriction was achieved by adding KCl (final concentration 156 
100 mmol/L) to the buffer. After several rinses, aortic rings were pre-constricted by adding 157 
increasing concentrations of phenylephrine (Sigma, Taufkirchen Germany; 10-9 to 10-3 mol/L) to 158 
around 70 % of maximal KCl constriction. Relaxation to increasing concentrations of acetylcholine 159 
(Sigma, Taufkirchen Germany; 10-9 to 10-2 mol/L) and sodium nitroprusside (Sigma; 10-9 to 10-2 160 
mol/L) were recorded until no further changes were observed in order to determine endothelial-161 
dependent and endothelial-independent vasodilation, respectively.     162 
 163 
In situ mitochondrial respiration 164 
Mitochondrial respiration was measured in situ from permeabilized cardiac and diaphragm fibers 165 
using high resolution respirometry (Oxygraph-2k: Oroboros Instruments, Innsbruck, Austria), as 166 
previously described (5). Dissected fibers were immediately placed in ice-cold BIOPS (2.77 mM 167 
CaK2EGTA buffer, 7.23 mM K2EGTA buffer, 20 mM imidazole, 20 mM taurine, 50 mM 2-(N-168 
morpholino)ethanesulfonic acid hydrate, 0.5 mM dithiothreitol, 6.56 mM MgCl2·6H2O, 5.77 mM 169 
Na2ATP and 15 mM Na2PCr (pH 7.1)) and under a microscope carefully dissected in 2 ml BIOPS 170 
at 4oC and permeabilized in saponin (50 µg/ml) for 30 min. Fiber bundles were then transferred to 171 
2 ml ice cold mitochondrial respiration medium (MiR05; 0.5 mM EGTA, 3mM MgCl2·6H2O, 172 
60mM Lactobionic acid, 20mM taurine, 10mM KH2PO4, 20mM HEPES, 110mM D-Sucrose, 1 173 
g/L BSA essentially fatty acid free, pH 7.1) and gently agitated for 10 minutes at 4oC before placed 174 
in a 2 mL oxygraph chamber incubated in MIR05 at 37°C oxygenated at ~300-400 µM (Oxygraph-175 
2k, Oroboros, Innsbruck, Austria). All experiments were performed in duplicates. A protocol 176 
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evaluating both leak (L) and oxidative phosphorylation (P) respiration states in complex I (CI) and 177 
complex I+II (CI+II) was assessed by addition of malate (2mM) and glutamate (10mM), followed 178 
by saturating ADP (5mM), and then succinate (10mM), respectively. All measurements were 179 
normalized to muscle wet weight and are presented as pmol O2
.sec-1.mg-1. In addition, the 180 
respiratory control ratio (RCR) was calculated as the ratio of maximal CI (P CI) to leak state (L CI) 181 
respiration, and also a substrate control ratio (SRC) was calculated as P CI to P CI + II.  182 
 183 
Tissue analyses  184 
Fiber typing and cross sectional-area analyses were performed on diaphragm sections, as 185 
previously described (5). Protein expression of MuRF1, MAFbx, NADPH oxidase (subunit 186 
gp91phox), myosin heavy chain, and eNOS (phosphorylated and acetylated) was assessed by western 187 
blot, while enzyme activity of NADPH oxidase, catalase, and superoxide dismutase was quantified 188 
in a photometric manner, as previously described (5). All data are presented as fold change relative 189 
to sham.  190 
  191 
Statistical analyses 192 
Data are presented as mean±SEM. Between-group differences in terms of physical characteristics, 193 
cardiac function, 9ሶ 2peak, mitochondrial function, protein expression, and enzyme activity were 194 
assessed by one-way ANOVA (Bonferroni post hoc) or non-parametric Kruskal-Wallis ('XQQ¶V195 
post hoc). Endothelial function (group X concentration) as well as force-frequency (group X 196 
frequency) and fatigue protocols (group X time) from each skeletal muscle were assessed by two-197 
way repeated measures ANOVA with Bonferroni post hoc analysis. Statistical significance was 198 
accepted as P<0.05.   199 
  200 
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Results 201 
Smoke exposure in mice reduced body weight by 26 % (P<0.05; Fig. 1A) and impaired exercise 202 
capacity by 15 % (P<0.05; Fig. 1B), however the latter was normalized following exercise training 203 
(P>0.05; Fig. 1B). In addition, in line with our hypothesis cigarette smoke exposure did not cause 204 
the development of overt emphysema, as demonstrated by no discernable alveolar destruction (i.e., 205 
mean linear intercept remained unchanged; P>0.05; Fig. 1C) and by the absence of pulmonary 206 
hypertension (i.e., right-ventricular systolic pressures were unchanged; P>0.05; Fig. 1D). 207 
Similarly, no differences were found between groups in terms of tibia length or skeletal muscle wet 208 
weights (P>0.05).     209 
 210 
Smoke-induced extrapulmonary impairments  211 
Heart: Heart weight remained unaltered following cigarette smoking (P>0.05). In addition, 212 
while echocardiography revealed that left ventricular function was not impaired by smoking 213 
(P>0.05; Table 1), right ventricular systolic function was reduced compared to controls by ~20 % 214 
as assessed by TAPSE (P<0.05; Table 1). To determine whether mitochondrial dysfunction may 215 
underlie this impairment, we further assessed mitochondrial respiration in fibers from the right and 216 
left ventricle, but found no differences (P>0.05; Fig. 2A-B).   217 
Peripheral endothelium: The effect of smoking on peripheral endothelial function was 218 
assessed from isolated aortic rings for both endothelial-dependent and -independent vasodilation 219 
(i.e., relaxation). Stimulation of aortic rings with increasing concentrations of acetylcholine 220 
revealed that smoking was associated with impaired endothelial-dependent vasodilation (P<0.05; 221 
Fig. 3A), with smoke-exposed mice achieving only 70±7 % of their maximal dilation compared to 222 
control mice values of 91±3 % (P<0.01). In contrast, smoke exposure did not impair endothelium-223 
independent vasodilation (P>0.05; Fig. 3B), with maximal vasodilation values of 100% achieved 224 
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in both groups (P>0.05). To determine potential mechanisms underlying these functional 225 
impairments, we further assessed protein expression of phosphorylated eNOS and acetylated eNOS 226 
in the aorta but found no differences between control and smoke-exposed mice (P>0.05). 227 
Respiratory and limb skeletal muscles: Compared to controls, diaphragm fiber bundles 228 
from smoking mice were weaker by an average of 15±2 % (range: 11 - 19%; P<0.05; Fig. 4A), 229 
which occurred at the lower and more clinically-relevant frequencies of 1, 15, 30, and 50 Hz. 230 
However, no differences were discerned during the fatigue protocol between groups. In contrast to 231 
the diaphragm, smoking had no adverse effect on limb muscle contractile function for either the 232 
glycolytic EDL muscle (Fig. 4B) or oxidative soleus muscle (Fig. 4C), or on relative force during 233 
the fatigue protocol (P>0.05; data not shown). As these data suggested the diaphragm was more 234 
susceptible to cigarette smoke-induced impairments, we focused thereafter on this specific skeletal 235 
muscle. Histological analyses of the diaphragm between control and smoke-exposed mice revealed 236 
no structural changes in terms of fiber cross-sectional area (fast and slow twitch: 1077±102 vs. 237 
1222±82 ȝm2 and 895±123 vs. 877±76 ȝm2, respectively; P>0.05) or fiber proportions (fast and 238 
slow twitch: 92±1 vs. 92±1 % and 8±1 vs. 8±1 %, respectively; P>0.05). In contrast, while the 239 
protein expression of NADPH oxidase, a marker of oxidative stress, was unaltered between groups 240 
(P>0.05; 5A), the more functional measure of enzyme activity was increased by 111 % (P<0.05; 241 
Fig. 5B). Similarly, the protein expression of MAFbx (a key marker of protein degradation) was 242 
also increased by 65 % in smokers compared to controls (P<0.05; 5C). In contrast, however, the 243 
protein expression of MuRF1 (another marker of protein degradation) was not different between 244 
groups (P>0.05; 5D), as was the case for the contractile protein myosin heavy chain (1.00±0.17 vs. 245 
0.90±0.15; P>0.05). We further assessed whether mitochondrial dysfunction could be contributing 246 
to the diaphragm muscle weakness following smoke exposure, however in situ mitochondrial 247 
respiration of permeabilized fibers was not different between groups (P>0.05; Fig. 2C).   248 
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  249 
Effects of high-intensity exercise training in smoke-exposed mice 250 
Six weeks of exercise training normalized the smoke-induced reduction in exercise capacity (Fig. 251 
1B), while also improving left ventricular systolic function (i.e., ejection fraction and fractional 252 
shortening) when compared to sedentary smoke-exposed mice (P<0.05; Table 1). In addition, 253 
exercise essentially reversed the smoke-induced impairment of TAPSE, suggesting right 254 
ventricular function was normalized (P<0.05; Table 1), while also reversing peripheral endothelial 255 
dysfunction such that maximal endothelium-dependent dilation was normalized to control values 256 
(P>0.05; Fig. 3A). In line with this, we found the protein expression of phosphorylated eNOS to 257 
be increased in the aorta of smoke-trained mice compared to both control and smoke-exposed 258 
sedentary mice (P<0.05). Importantly, smoke-induced diaphragm contractile dysfunction was also 259 
reversed by exercise training to similar values of that observed in control mice (P>0.05; Fig. 4A), 260 
which was also the case for both the enzyme activity of NADPH oxidase (P>0.05; Fig. 5B) and the 261 
protein expression of MAFbx (P>0.05; Fig. 5C). Nevertheless, no differences were subsequently 262 
found between control, smoking, and smoke-trained mice in terms of the anti-oxidative enzyme 263 
activity of superoxide dismutase (1.00±0.09 vs. 1.22±0.22 vs. 1.30±0.23, respectively; P>0.05) or 264 
catalase (1.00±0.13 vs. 1.01±0.13 vs. 0.83±0.12, respectively; P>0.05). Furthermore, exercise 265 
training had no influence on the expression of other proteins (e.g., myosin heavy chain, MuRF1, 266 
NADPH oxidase), on fiber properties (i.e. cross-sectional area and type), or on mitochondrial 267 
function (Fig. 2C; all P>0.05).  268 
  269 
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Discussion    270 
The main findings of this study include: 1) cigarette smoking induced functional impairments to 271 
the heart, peripheral endothelium, and respiratory muscle, which occurred in the absence of overt 272 
emphysema and these likely converged to reduce exercise capacity; and 2) high-intensity exercise 273 
training reversed these smoke-induced extrapulmonary impairments in line with normalizing 274 
exercise capacity. Collectively, therefore, our findings may have important clinical implications as 275 
they suggest that cigarette smokers in the absence of emphysema likely develop simultaneous 276 
extrapulmonary impairments to the heart, peripheral endothelium, and diaphragm that exacerbate 277 
exercise intolerance (11, 31), but such maladaptations could be reversed by the non-278 
pharmacological intervention of exercise training.  279 
 280 
Smoke exposure and skeletal muscle function  281 
Skeletal muscle dysfunction is a key component of COPD (19) and is associated with numerous 282 
adaptations (e.g., fiber atrophy, mitochondrial dysfunction, and increased ROS) (2, 3, 18, 24), yet 283 
numerous studies have yielded contradictory results with some (24, 28), but not all (7, 34), showing 284 
contractile impediments in the lower limbs. In these previous studies, however, overt emphysema 285 
had either developed (7, 24) or was not reported (18, 28), leaving it difficult to discriminate whether 286 
the cigarette smoke or emphysema was the causal factor underlying skeletal muscle dysfunction. 287 
Our study indicates that cigarette exposure in the absence of emphysema does not induce limb 288 
muscle contractile dysfunction, as supported by findings in both highly oxidative (i.e. soleus) and 289 
glycolytic (i.e., EDL) muscles. In addition, muscle disuse may have also confounded previous 290 
studies where limb muscle dysfunction was reported, as recent data demonstrated physical 291 
inactivity combined with smoke-induced emphysema significantly exacerbates limb muscle 292 
impairments (7). In the current experiments, therefore, we also assessed the main muscle of 293 
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respiration, the diaphragm, which is not only constantly active (i.e., thus attenuating any potential 294 
confounding factors associated with disuse) but also is thought to play a direct role in the 295 
pathogenesis of dyspnea (a key symptom in smokers even without overt COPD (11)). In the present 296 
study, we provide novel evidence that prolonged smoking induces diaphragm contractile 297 
dysfunction that is independent of lung structural damage, with fiber bundles ~15-20 % weaker 298 
compared to control mice. These data suggest, therefore, a greater sensitivity of respiratory rather 299 
than locomotor striated muscle to cigarette smoke-induced dysfunction. Furthermore, this loss of 300 
function was not due to muscle atrophy as force was normalized to muscle density, which suggests 301 
fiber weakness induced by smoking was the result of intracellular impairments (i.e., contractile 302 
dysfunction).  303 
 304 
While diaphragm muscle weakness in emphysema has previously been observed in diaphragm 305 
fibers from humans (23) and animals (32), we are the first to provide direct evidence that cigarette 306 
smoke exposure can lead to diaphragm fiber weakness in the period preceding lung structural 307 
damage. The mechanisms underlying the smoke-induced diaphragm muscle weakness may be 308 
related to an increase in oxidative stress and protein degradation, as NADPH oxidase activity (but 309 
not protein content) and MAFbx protein expression was increased in the diaphragm of smoking 310 
mice, but these were attenuated in the smoke-exercise trained mice in parallel with normalized 311 
contractile function. These findings compliment previous studies, which also reported increased 312 
levels of oxidative stress and oxidative protein modifications in the diaphragm following prolonged 313 
cigarette smoking in mice (2, 3). However, contrary to data from the soleus muscle (29), 314 
mitochondrial dysfunction was not present in diaphragm fibers following prolonged smoke 315 
exposure, which suggests a low oxidative phosphorylation capacity was unlikely mediating the 316 
smoke-induced respiratory muscle weakness. Taken together, therefore, our data support a role for 317 
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cigarette smoking as a causal mechanism in diaphragm muscle weakness, potentially mediated by 318 
elevated oxidative stress levels and activation of proteolytic pathways, which likely predisposes 319 
many smokers to respiratory dysfunction in the period preceding emphysema (11). 320 
 321 
Smoke exposure and cardiovascular function 322 
Following prolonged smoke exposure cardiac dysfunction is known to develop, with right 323 
ventricular function particularly compromised (25), while peripheral vascular endothelial 324 
dysfunction is also manifest (27). Our study confirmed that right ventricular function is reduced 325 
and peripheral endothelial function is impaired following cigarette exposure, which occurred in the 326 
absence of overt emphysema. In addition, we also confirmed previous findings that right 327 
ventricular dysfunction can be reversed by exercise training (15). In order to better understand the 328 
mechanisms of these smoke-induced cardiac impairments, we assessed mitochondrial function in 329 
cardiac fibers. However, and in contrast to a previous study reporting impaired respiration in fibers 330 
from the left ventricle (30), we found no differences between groups in either the left or right 331 
ventricle, which suggests mitochondrial dysfunction is unlikely a key mechanism of smoke-332 
induced right ventricular dysfunction, at least in relation to the present animal model. In terms of 333 
the peripheral endothelium, we provide novel data that high-intensity exercise training can reverse 334 
smoke-induced peripheral vascular impairments, as endothelium-dependent vasodilation in aortic 335 
rings was normalized to control values following exercise training. We also found a significant 336 
increase in the protein expression of phosphorylated eNOS in smoke-trained mice, which may help 337 
explain how exercise mediated its benefits, as smoking is well known to reduce NO bioavailability 338 
and eNOS activity (4). However, why endothelial dysfunction was only observed at the higher 339 
rather than the lower acetylcholine concentrations in smoke-exposed mice is unclear, but it may be 340 
related to differences in membrane receptor sensitivity or density. Nevertheless, that data collected 341 
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from both animals (27) and humans (16, 26) show a similar trend after smoke exposure supports 342 
the physiological relevance of the present findings.  343 
 344 
If we take an integrative approach, it could be speculated that diaphragm muscle weakness induced 345 
by smoke-exposure is mediated, in part, by upstream impairments related to cardiac and peripheral 346 
endothelial dysfunction that limit blood flow to induce local hypoxia, with the latter suggested as 347 
a key mechanism underpinning skeletal muscle dysfunction in COPD (19). Hypoxia has been 348 
shown in diaphragm fiber bundles to potentiate ROS production which, in turn, directly impair 349 
subsequent force generation (22). As such, our overall findings of impaired central and peripheral 350 
vascular function coupled with diaphragm muscle weakness in concert with elevated markers of 351 
ROS suggest hypoxia could be a putative mechanism for the smoke-induced respiratory muscle 352 
weakness.     353 
  354 
Animal model of cigarette smoke exposure  355 
The uncertainty related to the role of cigarette smoke exposure on extrapulmonary impairments 356 
had previously been clouded by the fact that emphysema was usually developed secondary to 357 
cigarette exposure (2, 3, 7, 13) or that lung indices of emphysema were not measured (18, 28). In 358 
the current study we selected a period of 20 weeks for smoke exposure so animals would not 359 
develop overt emphysema, which is generally documented after 24 weeks in mice (9, 13). 360 
Furthermore, the A/J mouse strain we studied is moderately susceptible to lung destruction 361 
following smoke exposure (21), but not as sensitive (e.g., C57BL/6J) or resistant as other strains 362 
(e.g., NZWLac/J) (14, 35). Collectively, therefore, the present data support our objective and 363 
reinforce the clinical translation of our data, as prolonged smoke exposure resulted in no signs of 364 
emphysema, while numerous multi-organ impairments converged concomitant with an impaired 365 
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exercise capacity of ~20%, with the latter value similar to that reported in patients at high risk of 366 
developing emphysema (11). Nevertheless, we acknowledge the possibility our mouse model may 367 
have still induced lung injury and airflow limitation despite the absence of emphysema 368 
histologically. As such, the addition of lung functional measurements including measuring airway 369 
resistance would have provided further clarity on this issue. Furthermore, as the present study 370 
assessed female mice only, it also remains unclear whether the observed multi-organ impairments 371 
would have been reduced or even exacerbated in males exposed to the same amount of cigarette 372 
smoke.    373 
 374 
Conclusion 375 
High-intensity exercise training reversed cigarette smoke-induced extrapulmonary impairments to 376 
the heart, the peripheral vascular endothelium, and the diaphragm as well normalizing exercise 377 
capacity, which occurred before the onset of overt emphysema. These findings suggest, therefore, 378 
that cigarette smokers in the absence of emphysema likely develop extrapulmonary impairments 379 
that exacerbate exercise intolerance, but exercise training can reverse these detrimental 380 
consequences.     381 
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Figure Legends 488 
Fig. 1  Body weight (A), exercise capacity (B), mean linear intercept (Lm; C) and right 489 
ventricular systolic pressure (RVSP; D) of control, smoking, and smoking mice that performed 490 
high-intensity interval training (HIIT). That lung destruction (C) or pulmonary hypertension (D) 491 
did not differ between groups supports the contention that overt emphysema was not developed in 492 
smoke-exposed mice. *P<0.05 vs. Control.    493 
 494 
Fig. 2  In situ mitochondrial respiration states and the respective control ratios in 495 
permeabilized fibers of the left ventricle (A), right ventricle (B), and diaphragm (C), as assessed 496 
from control, smoking, and smoking mice that performed high-intensity interval training (HIIT). 497 
Respiration states were assessed, in turn, including: CI leak, complex I leak respiration following 498 
addition of malate and glutamate; CI, complex I phosphorylated state following addition of ADP; 499 
CII, complex II phosphorylated state following addition of succinate. No significant differences 500 
were found between groups for all measures.          501 
 502 
Fig. 3  Peripheral in vitro endothelial-dependent (A) and -independent (B) function in 503 
response to increasing acetylcholine and sodium nitroprusside (SNP) concentrations, as assessed 504 
in isolated aortic rings from control, smoking, and smoking mice that performed high-intensity 505 
interval training (HIIT). *P<0.05 vs. Control and Smoking+HIIT; #P<0.05 vs. Smoking+HIIT       506 
 507 
Fig. 4  In vitro respiratory and lower limb skeletal muscle contractile function assessed 508 
across a range of stimulation frequencies in the diaphragm (A), EDL (B), and soleus (C) for control, 509 
smoking, and smoking mice that performed high-intensity interval training (HIIT). *P<0.05 vs. 510 
Smoking.    511 
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 512 
Fig. 5  Protein expression (A) and enzyme activity (B) of NADPH oxidase as well as 513 
protein expression of MAFbx (C) and MuRF1 (D) in the diaphragm from control, smoking, and 514 
smoking mice that performed high-intensity interval training (HIIT). Representative blots for each 515 
protein are also provided in the upper panel, which were normalized to the loading control GAPDH 516 
for control (c), smoking (s), and smoking mice that performed HIIT (H).  *P<0.05 vs. Control and 517 
Smoking+HIIT; #P<0.05 vs. Control. 518 
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